Fritz Lang
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
-
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 11
- Cancer Treatment and Pharmacology 6
- Colorectal Cancer Treatments and Studies 6
- Pancreatic and Hepatic Oncology Research 3
- Neutropenia and Cancer Infections 2
- Lung Cancer Research Studies 1
-
- Gastric Cancer Management and Outcomes 2
- Co-authors
- Werner Scheithauer (16 shared papers)Gabriela Kornek (15 shared papers)D. Depisch (15 shared papers)Markus Raderer (8 shared papers)Bruno Schneeweiß (6 shared papers)B. Schüll (6 shared papers)E. Kovats (6 shared papers)Katharina Schmid (3 shared papers)
- Journals
- British Journal of Cancer (4 papers)Journal of Clinical Oncology (4 papers)Oncology (2 papers)Acta Oncologica (1 paper)Anti-Cancer Drugs (1 paper)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Fritz Lang
16 papers receiving 643 citations
Peers
Comparison fields: 5 of 50
- Oncology 441
- Hepatology 45
- Pulmonary and Respiratory Medicine 154
- Cancer Research 69
- Surgery 162
Countries citing papers authored by Fritz Lang
This map shows the geographic impact of Fritz Lang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fritz Lang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fritz Lang more than expected).
Fields of papers citing papers by Fritz Lang
This network shows the impact of papers produced by Fritz Lang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fritz Lang. The network helps show where Fritz Lang may publish in the future.
Co-authors
The 25 scholars most cited alongside Fritz Lang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 147 | |
| 2 | 2004 | 118 | |
| 3 | 2003 | 102 | |
| 4 | 2005 | 49 | |
| 5 | 1999 | 41 | |
| 6 | Treatment of advanced breast cancer with docetaxel and gemcitabine with and without human granulocyte colony-stimulating factor. | 2002 | 40 |
| 7 | 2002 | 37 | |
| 8 | 2001 | 36 | |
| 9 | 2002 | 24 | |
| 10 | 2002 | 21 | |
| 11 | 2003 | 18 | |
| 12 | 2007 | 14 | |
| 13 | 2006 | 10 | |
| 14 | 2009 | 8 | |
| 15 | 2004 | 4 | |
| 16 | 1999 | 2 |
About Fritz Lang
Fritz Lang is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Epidemiology and Hepatology, having authored 16 papers that have together received 671 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (6 papers), Colorectal Cancer Treatments and Studies (6 papers), Pancreatic and Hepatic Oncology Research (3 papers), Neuroendocrine Tumor Research Advances (2 papers), Gastric Cancer Management and Outcomes (2 papers), Neutropenia and Cancer Infections (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Oncology (441 citations), Hepatology (45 citations), Pulmonary and Respiratory Medicine (154 citations), Cancer Research (69 citations) and Surgery (162 citations). Fritz Lang has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Werner Scheithauer, Gabriela Kornek, D. Depisch, Markus Raderer, Bruno Schneeweiß, B. Schüll, E. Kovats, Katharina Schmid, A. Lenauer and K. Haider. Their work appears in journals such as British Journal of Cancer, Journal of Clinical Oncology, Oncology, Acta Oncologica and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.